Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADDJ53
1996

Cisplatin and Taxol Activate Different Pathways for GADD153 Expression

publication Evidence: moderate

Author Information

Author(s): DP Gately, A Sharma, RD Christen, SB Howell

Primary Institution: University of California, San Diego

Hypothesis

Do cisplatin and taxol activate GADD153 expression through different signal transduction pathways?

Conclusion

Cisplatin and taxol activate GADD153 expression through distinct mechanisms, with cisplatin causing a greater increase in GADD153 mRNA levels than taxol.

Supporting Evidence

  • Cisplatin produced a 10-fold increase in GADD153 mRNA compared to taxol.
  • Taxol activated the GADD153 promoter in a concentration-dependent manner.
  • Tyrphostin B46 inhibited the activation of the GADD153 promoter by cisplatin.

Takeaway

This study shows that two cancer drugs, cisplatin and taxol, work differently in how they make a gene called GADD153 active, which helps cells respond to damage.

Methodology

The study involved transfecting human ovarian carcinoma cells with a GADD153 promoter-luciferase construct and measuring luciferase activity and GADD153 mRNA levels after drug treatment.

Limitations

The specific transcription factors involved in GADD153 induction by cisplatin remain unidentified.

Participant Demographics

Human ovarian carcinoma cells (2008 cell line) were used in the study.

Statistical Information

P-Value

0.009

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication